Effects of azithromycin on Pseudomonas aeruginosa isolates from catheter-associated urinary tract infection

Experimental and Therapeutic Medicine

Volumn 9, Issue 2, 2015, Pages 569-572

  Xu, Zhi Gang ^a   Gao, Yu ^b   He, Jian Guo ^a   Xu, Wei Feng ^a   Jiang, Mei ^a   Jin, Huan Sheng ^a  

^a Chongqing Red Cross Hospital   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Azithromycin; Biofilm; Pseudomonas aeruginosa; Swimming; Urinary tract infection; Virulence factor

Indexed keywords

AMIKACIN; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; ELASTASE; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; NETILMICIN; PIPERACILLIN; RHAMNOLIPID; RHAMNOSE; TETRACYCLINE; VIRULENCE FACTOR;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; CATHETER INFECTION; CELL ADHESION; COLONY FORMING UNIT; CONTROLLED STUDY; DISK DIFFUSION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SWIMMING; SWIMMING MOTILITY; URINARY CATHETER; URINARY TRACT INFECTION;

EID: 84918778416     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2120     Document Type: Article

References (23)

1. Ronald A: The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113 (Suppl 1A): 14S-19S, 2002.
2. Jarvis WR and Martone WJ: Predominant pathogens in hospital infections. J Antimicrob Chemother 29 (Suppl A): 19-24, 1992.
3. Stickler DJ: Bacterial biofilms and the encrustation of urethral catheters. Biofouling 9: 293-305, 1996.
4. Nickel JC, Ruseska I, Wright JB and Costerton JW: Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother 27: 619-624, 1985.
5. Cole SJ, Records AR, Orr MW, Linden SB and Lee VT: Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms. Infect Immun 82: 2048-2058, 2014.
6. Tielen P, Rosin N, Meyer AK, et al: Regulatory and metabolic networks for the adaptation of Pseudomonas aeruginosa biofilms to urinary tract-like conditions. PLoS One 8: e71845, 2013.
7. Narten M, Rosin N, Schobert M and Tielen P: Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance. Curr Microbiol 64: 7-16, 2012.
8. Ministry of Health, Administration of Traditional Chinese Medicine and General Logistics Department of Health: Guidelines for Clinical Use of Antibiotics. Chinese Medical Association, Beijing, China, 2004.
9. Clinical Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; 21st informational supplement. M100-S21, Vol 31. Clinical Laboratory Standards Institute, Wayne, PA, USA, 2011.
10. Wang Q, Sun FJ, Liu Y, Xiong LR, Xie LL and Xia PY: Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and-negative clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother 54: 2707-2711, 2010.
11. Naik DN, Wahidullah S and Meena RM: Attenuation of Pseudomonas aeruginosa virulence by marine invertebrate-derived Streptomyces sp. Lett Appl Microbiol 56: 197-207, 2013.
12. Tomaras AP, Dorsey CW, Edelmann RE and Actis LA: Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149: 3473-3484, 2003.
13. Bala A, Kumar R and Harjai K: Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections. J Med Microbiol 60: 300-306, 2011.
14. Saint S and Lipsky BA: Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med 159: 800-808, 1999.
15. Vranes J: Effect of subminimal inhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to polystyrene. J Chemother 12: 280-285, 2000.
16. Wretlind B and Pavlovskis OR: Pseudomonas aeruginosa elastase and its role in pseudomonas infections. Rev Infect Dis 5 (Suppl 5): S998-S1004, 1983.
17. Saulnier JM, Curtil FM, Duclos MC and Wallach JM: Elastolytic activity of Pseudomonas aeruginosa elastase. Biochim Biophys Acta 995: 285-290, 1989.
18. Bejarano PA, Langeveld JP, Hudson BG and Noelken ME: Degradation of basement membranes by Pseudomonas aeruginosa elastase. Infect Immun 57: 3783-3787, 1989.
19. Kharazmi A, Döring G, Høiby N and Valerius NH: Interaction of Pseudomonas aeruginosa alkaline protease and elastase with human polymorphonuclear leukocytes in vitro. Infect Immun 43: 161-165, 1984.
20. Jacquot J, Tournier JM and Puchelle E: In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase. Infect Immun 47: 555-560, 1985.
21. Caiazza NC, Shanks RM and O'Toole GA: Rhamnolipids modulate swarming motility patterns of Pseudomonas aeruginosa. J Bacteriol 187: 7351-7361, 2005.
22. van Delden C, Köhler T, Brunner-Ferber F, François B, Carlet J, Pechère JC: Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial. Intensive Care Med 38: 1118-1125, 2012.
23. Marschall J, Carpenter CR, Fowler S, Trautner BW; CDC Prevevention Epicenters Program: Antibiotic prophylaxis for urinary tract infections after removal of urinary catheter: meta-analysis. BMJ 346: f3147, 2013.